{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:51:59Z","timestamp":1761310319790},"reference-count":19,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ataxia-telangiectasia mutated (ATM), the protein defective in ataxia-telangiectasia, plays a central role in DNA damage response and signaling to cell cycle checkpoints. We describe here a cell line from a patient with an ataxia-telangiectasia\u2013like clinical phenotype defective in the p53 response to radiation but with normal ATM activation and efficient downstream phosphorylation of other ATM substrates. No mutations were detected in ATM cDNA. A normal level of interaction between p53 and peptidyl-prolyl-isomerase Pin1 suggests that posttranslational modification was intact in these cells but operating at reduced level. Defective p53 stabilization was accompanied by defective induction of p53 effector genes and failure to induce apoptosis in response to DNA-damaging agents. Continued association between p53 and murine double minute-2 (Mdm2) occurred in irradiated ATL2ABR cells in response to DNA damage, and incubation with Mdm2 antagonists, nutlins, increased the stabilization of p53 and its transcriptional activity but failed to induce apoptosis. These results suggest that ATM-dependent stabilization of p53 and induction of apoptosis by radiation involve an additional factor(s) that is defective in ATL2ABR cells. (Cancer Res 2006; 66(6): 2907-12)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-3428","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T22:23:19Z","timestamp":1142461399000},"page":"2907-2912","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Defective p53 Response and Apoptosis Associated with an Ataxia-Telangiectasia\u2013like Phenotype"],"prefix":"10.1158","volume":"66","author":[{"given":"Nuri","family":"Gueven","sequence":"first","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier J.","family":"Becherel","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Birrell","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Chen","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giannino","family":"DelSal","sequence":"additional","affiliation":[{"name":"3Laboratorio Nazionale CIB, Dipartimento di Biochimica, Biofisica e Chimica delle Macromolecole, Trieste, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Carney","sequence":"additional","affiliation":[{"name":"4Radiation Oncology Research Laboratory, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padraic","family":"Grattan-Smith","sequence":"additional","affiliation":[{"name":"5Sydney Children's Hospital, Randwick, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin F.","family":"Lavin","sequence":"additional","affiliation":[{"name":"1Queensland Institute of Medical Research;"},{"name":"2Central Clinical School, University of Queensland, Brisbane, Queensland, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,3,15]]},"reference":[{"key":"2022061622143546700_B1","unstructured":"Boder E, Sedgwick RP. In: Vinkin PJ, Bruyn W, Klawans HL, editors. Hereditary neuropathies and spinocerebellar atrophies. Liss (AR): New York; 1991. p. 347\u2013423."},{"key":"2022061622143546700_B2","doi-asserted-by":"crossref","unstructured":"Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol\u20081997; 15: 177\u2013202.","DOI":"10.1146\/annurev.immunol.15.1.177"},{"key":"2022061622143546700_B3","doi-asserted-by":"crossref","unstructured":"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature\u20082003; 421: 499\u2013506.","DOI":"10.1038\/nature01368"},{"key":"2022061622143546700_B4","doi-asserted-by":"crossref","unstructured":"Lavin MF, Delia D, Chessa L. Workshop on ataxia telangiectasia; ATM and DNA damage response; Belgirate, Italy June 2005. EMBO Rep\u20082006; 7: 154\u201360.","DOI":"10.1038\/sj.embor.7400629"},{"key":"2022061622143546700_B5","unstructured":"Mirzoeva OK, Petrini JH. DNA replication-dependent nuclear dynamics of the Mre11 complex. Mol Cancer Res\u20082003; 1: 207\u201318."},{"key":"2022061622143546700_B6","doi-asserted-by":"crossref","unstructured":"Cerosaletti K, Concannon P. Independent roles for nibrin and Mre11-Rad50 in the activation and function of ATM. J Biol Chem\u20082004; 279: 38813\u20139.","DOI":"10.1074\/jbc.M404294200"},{"key":"2022061622143546700_B7","doi-asserted-by":"crossref","unstructured":"Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J\u20082003; 22: 5612\u201321.","DOI":"10.1093\/emboj\/cdg541"},{"key":"2022061622143546700_B8","doi-asserted-by":"crossref","unstructured":"Kozlov S, Gueven N, Keating K, Ramsay J, Lavin MF. ATP activates ataxia-telangiectasia mutated (ATM) in vitro. Importance of autophosphorylation. J Biol Chem\u20082003; 278: 9309\u201317.","DOI":"10.1074\/jbc.M300003200"},{"key":"2022061622143546700_B9","doi-asserted-by":"crossref","unstructured":"Zacchi P, Gostissa M, Uchida T, et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature\u20082002; 419: 853\u20137.","DOI":"10.1038\/nature01120"},{"key":"2022061622143546700_B10","doi-asserted-by":"crossref","unstructured":"Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem\u20082001; 276: 42462\u20137.","DOI":"10.1074\/jbc.C100466200"},{"key":"2022061622143546700_B11","doi-asserted-by":"crossref","unstructured":"Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J\u20082003; 22: 6068\u201377.","DOI":"10.1093\/emboj\/cdg579"},{"key":"2022061622143546700_B12","doi-asserted-by":"crossref","unstructured":"Haupt Y, Barak Y, Oren M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J\u20081996; 15: 1596\u2013606.","DOI":"10.1002\/j.1460-2075.1996.tb00504.x"},{"key":"2022061622143546700_B13","unstructured":"Moll UM, Petrenko O. The MDM2\u201353 interaction. Mol Cancer Res\u20082003; 1: 1001\u20138."},{"key":"2022061622143546700_B14","unstructured":"Kumar S, Lavin MF. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ\u20081996; 3: 255\u201367."},{"key":"2022061622143546700_B15","unstructured":"Duchaud E, Ridet A, Stoppa-Lyonnet D, Janin N, Moustacchi E, Rosselli F. Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Cancer Res\u20081996; 56: 1400\u20134."},{"key":"2022061622143546700_B16","doi-asserted-by":"crossref","unstructured":"Thompson T, Tovar C, Yang H, et al. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J Biol Chem\u20082004; 279: 53015\u201322.","DOI":"10.1074\/jbc.M410233200"},{"key":"2022061622143546700_B17","doi-asserted-by":"crossref","unstructured":"Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol\u20082003; 15: 164\u201371.","DOI":"10.1016\/S0955-0674(03)00003-6"},{"key":"2022061622143546700_B18","doi-asserted-by":"crossref","unstructured":"Berger M, Stahl N, Del Sal G, Haupt Y. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol Cell Biol\u20082005; 25: 5380\u20138.","DOI":"10.1128\/MCB.25.13.5380-5388.2005"},{"key":"2022061622143546700_B19","doi-asserted-by":"crossref","unstructured":"Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature\u20081994; 370: 220\u20133.","DOI":"10.1038\/370220a0"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/6\/2907\/2561300\/2907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/6\/2907\/2561300\/2907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:51:55Z","timestamp":1655427115000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/6\/2907\/527473\/Defective-p53-Response-and-Apoptosis-Associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,15]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,3,15]]},"published-print":{"date-parts":[[2006,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-3428","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,15]]}}}